RSS Feeds
Search

Companies

Companies

Displaying 11..11 of 11 - per page Previous page
Order by
CytoGenix
CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating technology. More
Displaying 11..11 of 11 - per page Previous page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Infectious Disease Diagnostic Markets
Aug 2009 - 180 pages - $3,500
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
West Nile Virus Infections - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Innovations in Molecular Diagnostics for Infectious Diseases
Nov 2011 - 168 pages - $3,835
Innovations in Combating Infectious Diseases: Opportunities in therapeutics and diagnostics through application of proteomics, genomics, nanotechnology, and novel sources of lead generation
Jun 2010 - 250 pages - $3,835
Deals and alliances in infectious diseases
Jun 2006 - 1458 pages - $2,495
West Nile Virus Infections - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
Company Financials: Achillion Pharmaceuticals, Inc.
Jan 2010 - $75
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us